English (United States)
 

EFGCP article: Cross-Border Access to clinical Trials in the EU

11/11/20
reduce font Size enlarge font Size print content
 
NWI4386QW07YL322.jpg

 

EFGCP article: Cross-Border Access to clinical Trials in the EU

 

The article on the Cross-Border Access to clinical Trials in the EU is now available for reading.

 

Today, access to clinical trials in Europe still differ per country.

A study has been conducted on Needs and Reality of the Clinical Trials in the EU and through a mixed methods design, it was possible to give an overview of the actual experience of stakeholders in order to analyze the current situation of cross-border access to clinical trials in the EU and identify the needs, challenges, and potential for facilitation of cross-border access.

 

Discover the outcomes of this study and the proposals made by the participants to improve the current system.

 

Click here to read the article: Cross Border Access to Clinical Trials

 

 

Contact:

EFGCP Secretariat

Rue de l’Industrie 4

BE-1000 Brussels, Belgium

Tel: +32.2.732 87 83

Website : http://www.efgcp.eu/

 

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.